This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Schistosoma mansoni | |
|---|---|
| Name | Schistosoma mansoni |
| Regnum | Animalia |
| Phylum | Platyhelminthes |
| Classis | Trematoda |
| Ordo | Diplostomida |
| Familia | Schistosomatidae |
| Genus | Schistosoma |
| Species | S. mansoni |
Schistosoma mansoni is a species of trematode parasite that causes intestinal schistosomiasis in humans. First described in the 19th century, it remains a major public health concern in parts of Africa, South America, and the Middle East. Its study intersects with tropical medicine, parasitology, and global health initiatives led by organizations and researchers.
Schistosoma mansoni belongs to the phylum Platyhelminthes and the family Schistosomatidae, classified alongside congeners such as species recognized during expeditions by David Livingstone and described in taxonomic revisions by institutions like the Natural History Museum, London and the Smithsonian Institution. Morphologically, adults display sexual dimorphism with a gynecophoral canal in males comparable to descriptions in classic texts by authors associated with the Royal Society and the Rockefeller Foundation. The adult worm measures several millimeters and exhibits tegumental features noted in monographs used by the London School of Hygiene & Tropical Medicine and the Pasteur Institute. Eggs are ovoid with a lateral spine, features catalogued in comparative keys used by the World Health Organization and university collections at Harvard University and Oxford University.
The life cycle involves definitive human hosts and intermediate freshwater snail hosts such as species of the genus Biomphalaria, documented in field studies from the Amazon Basin, the Nile surveys associated with projects funded by the Wellcome Trust, and Caribbean research collaborations with the University of the West Indies. Miracidia hatch from eggs and infect snails, transforming through sporocyst stages to produce cercariae, a process described in laboratory investigations at the Marine Biological Laboratory and the Max Planck Society. Cercariae penetrate human skin during contact with contaminated water bodies studied near the Congo River and Lake Victoria and mature into adult worms in the mesenteric veins, a migration pathway mapped in comparative anatomy collections at the Smithsonian Tropical Research Institute.
Schistosoma mansoni is endemic in sub-Saharan Africa, parts of South America including Brazil, and pockets of the Middle East, with prevalence documented in national surveys conducted by ministries of health collaborating with the World Health Organization and the Pan American Health Organization. Transmission hotspots have been associated with irrigation projects like those historically developed by entities such as the Aswan High Dam and agricultural initiatives reminiscent of colonial-era schemes tied to research archives at the British Library. Control programs in endemic countries have been supported by global partnerships involving UNICEF, the Bill & Melinda Gates Foundation, and academic consortia at the London School of Hygiene & Tropical Medicine. Migration, urbanization, and environmental change linked to policies debated at the United Nations influence shifting distribution patterns reported by surveillance networks run from centers such as the Centers for Disease Control and Prevention.
Pathogenesis results primarily from immune responses to eggs trapped in host tissues, a mechanism explored in immunology studies at institutions like the Karolinska Institutet and the Johns Hopkins University School of Medicine. Clinical manifestations range from acute Katayama fever referenced in historical clinical series archived at the Royal College of Physicians to chronic intestinal and hepatic disease described in textbooks used at the University of Cape Town and University of São Paulo. Complications include portal hypertension, splenomegaly, and growth impairment documented in field cohorts studied by researchers associated with the London School of Hygiene & Tropical Medicine and the Institut Pasteur. Co-infections and comorbidities have been evaluated in multicenter trials coordinated by the European Commission and philanthropic studies funded by the Rockefeller Foundation.
Diagnostic approaches include microscopy for ova detection in stool using techniques standardized by the World Health Organization and laboratory protocols disseminated by the Centers for Disease Control and Prevention, antigen detection assays developed at research centers like the Institut Pasteur, and serological tests used in screening campaigns run by ministries of health aligned with Pan American Health Organization guidelines. Imaging modalities for hepatosplenic disease are applied in clinical services at teaching hospitals such as Charité – Universitätsmedizin Berlin and Addenbrooke's Hospital. Molecular diagnostics including PCR assays have been advanced in laboratories at the Wellcome Sanger Institute and university centers collaborating with the European Molecular Biology Laboratory.
Praziquantel is the mainstay of treatment, deployed in mass drug administration campaigns coordinated by the World Health Organization and partners like Helen Keller International and the Schistosomiasis Control Initiative. Antiparasitic drug efficacy and resistance monitoring have been subjects of trials funded by the Bill & Melinda Gates Foundation and conducted at institutions such as Imperial College London. Control strategies integrate snail management historically investigated in projects involving the Food and Agriculture Organization and environmental interventions studied in collaborations with the International Water Management Institute. Vaccine research is underway in consortia including teams at the National Institutes of Health and industrial partners documented in grant portfolios of the European Commission.
Preventive measures emphasize safe water supply, sanitation infrastructure projects similar to those planned by the World Bank, health education programs implemented by UNICEF, and behavioral interventions evaluated in community trials led by the London School of Hygiene & Tropical Medicine and Johns Hopkins Bloomberg School of Public Health. Integrated control aligns with Sustainable Development Goals advanced at the United Nations General Assembly and regional health strategies coordinated by the African Union and the Pan American Health Organization. Surveillance, mapping, and elimination efforts rely on partnerships among national ministries, academic consortia, and international funders including the Bill & Melinda Gates Foundation and the World Health Organization.
Category:Parasitic diseases